We provide you with 20 years of free, institutional-grade data for MGTA stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MGTA. Explore the full financial landscape of MGTA stock.
| Reported Date | CIK | Ticker | Type |
|---|
Magenta Therapeutics, Inc(NASDAQ:MGTA) 
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant condi...
Website: http://www.magentatx.com
Founded: 2015
Full Time Employees: 70
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about MGTA stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.